跳至主要内容
临床试验/NCT03034421
NCT03034421终止不适用

Prevention of Pneumothorax Following Endoscopic Valve Therapy in Patients With Severe Emphysema

Heidelberg University2 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
38
试验地点
2
主要终点
Advent of pneumothorax within 90 days following valve implantation

研究概览

简要总结

Endoscopic valve therapy is an effective therapy for patients with severe emphysema and low interlobar collateral ventilation. Although, valve therapy is a minimal-invasive treatment approach, it is associated with complications the most common of which is pneumothorax with a rate of 18-25%. Modifying post-operative medical care including bed rest for 48 hours after valve implantation may reduce the risk of post-interventional pneumothorax.

详细描述

Patient enrolment and data acquisition is to be carried out on a prospective basis. It is planned to enrol a total of 130 patients with advanced emphysema and low collateral ventilation. Patients will be randomly assigned in a 1:1 ratio to receive modified medical care including a 48 bed rest or standard medical care following valve implantation. All patients will undergo treatment at one study centre in Heidelberg.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • FEV1 < 50%, RV>150%, TLC>100%
  • emphysema confirmed by computed tomography
  • pO2 >60 mmHg (with supplemental oxygen), pCO2 < 55 mmHg (room condition)
  • no significant collateral ventilation (assessed by fissure analysis and/or catheter-based measurement)
  • no COPD exacerbation within the past 8 weeks
  • daily use of < 20 mg Prednisolon
  • non-smoking for a minimum of 4 months prior to consent
  • Patient has provided written informed consent

排除标准

  • BMI < 18 kg/m²
  • clinically relevant bronchiectasis
  • failed cardiac clearance: defined as myocardial infarction within last 6 weeks, decompensation of heart failure
  • Prior lung resection (e.g. lobectomy)

结局指标

主要结局

Advent of pneumothorax within 90 days following valve implantation

时间窗: 90 days following valve implantation

Incidence of pneumothorax that is confirmed by radiological procedures within 90 days after implantation of valves.

次要结局

  • Lung function before and after valve therapy(30 and 90 days following valve implantation)
  • Excercise capacity before and after valve therapy(30 and 90 days following valve implantation)
  • Dyspnoe score before and after valve therapy(30 and 90 days following valve implantation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Felix JF Herth

Prof. Dr. med.

Heidelberg University

研究点 (2)

Loading locations...

相似试验